These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 21737274

  • 21. Synthesis and in vitro antitubercular activity of 4-aryl/alkylsulfonylmethylcoumarins as inhibitors of Mycobacterium tuberculosis.
    Jeyachandran M, Ramesh P, Sriram D, Senthilkumar P, Yogeeswari P.
    Bioorg Med Chem Lett; 2012 Jul 15; 22(14):4807-9. PubMed ID: 22726933
    [Abstract] [Full Text] [Related]

  • 22. Synthesis and antimycobacterial activity of azetidine-, quinazoline-, and triazolo-thiadiazole-containing pyrazines.
    Bonde CG, Peepliwal A, Gaikwad NJ.
    Arch Pharm (Weinheim); 2010 Apr 15; 343(4):228-36. PubMed ID: 20205198
    [Abstract] [Full Text] [Related]

  • 23. Identification, synthesis, and characterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site.
    Kristiansen M, Andersen B, Iversen LF, Westergaard N.
    J Med Chem; 2004 Jul 01; 47(14):3537-45. PubMed ID: 15214781
    [Abstract] [Full Text] [Related]

  • 24. Synthesis and antitubercular activity of 2-(substituted phenyl/benzyl-amino)-6-(4-chlorophenyl)-5-(methoxycarbonyl)-4-methyl-3,6-dihydropyrimidin-1-ium chlorides.
    Narayanaswamy VK, Nayak SK, Pillay M, Prasanna R, Coovadia YM, Odhav B.
    Chem Biol Drug Des; 2013 Feb 01; 81(2):219-27. PubMed ID: 23150983
    [Abstract] [Full Text] [Related]

  • 25. Facile one-pot synthesis and antimycobacterial evaluation of pyrazolo[3,4-d]pyrimidines.
    Trivedi A, Dodiya D, Surani J, Jarsania S, Mathukiya H, Ravat N, Shah V.
    Arch Pharm (Weinheim); 2008 Jul 01; 341(7):435-9. PubMed ID: 18574851
    [Abstract] [Full Text] [Related]

  • 26. Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: synthesis and in vitro anti-mycobacterial activity.
    Gasse C, Douguet D, Huteau V, Marchal G, Munier-Lehmann H, Pochet S.
    Bioorg Med Chem; 2008 Jun 01; 16(11):6075-85. PubMed ID: 18467107
    [Abstract] [Full Text] [Related]

  • 27. Synthesis of new pyrimidine-fused derivatives as potent and selective antidiabetic α-glucosidase inhibitors.
    Panahi F, Yousefi R, Mehraban MH, Khalafi-Nezhad A.
    Carbohydr Res; 2013 Oct 18; 380():81-91. PubMed ID: 23978663
    [Abstract] [Full Text] [Related]

  • 28. Tryptanthrin Analogues as Inhibitors of Enoyl-acyl Carrier Protein Reductase: Activity against Mycobacterium tuberculosis, Toxicity, Modeling of Enzyme Binding.
    Duca G, Pogrebnoi S, Boldescu V, Aksakal F, Uncu A, Valica V, Uncu L, Negres S, Nicolescu F, Macaev F.
    Curr Top Med Chem; 2019 Oct 18; 19(8):609-619. PubMed ID: 30834838
    [Abstract] [Full Text] [Related]

  • 29. Synthetic studies in butenonyl C-glycosides: Preparation of polyfunctional alkanonyl glycosides and their enzyme inhibitory activity.
    Bisht SS, Fatima S, Tamrakar AK, Rahuja N, Jaiswal N, Srivastava AK, Tripathi RP.
    Bioorg Med Chem Lett; 2009 May 15; 19(10):2699-703. PubMed ID: 19362832
    [Abstract] [Full Text] [Related]

  • 30. Synthesis and anti-mycobacterial activity of (E)-N'-(monosubstituted-benzylidene)isonicotinohydrazide derivatives.
    Lourenço MC, Ferreira Mde L, de Souza MV, Peralta MA, Vasconcelos TR, Henriques Md.
    Eur J Med Chem; 2008 Jun 15; 43(6):1344-7. PubMed ID: 17923172
    [Abstract] [Full Text] [Related]

  • 31. Advances in glycogen phosphorylase inhibitor design.
    Oikonomakos NG, Somsák L.
    Curr Opin Investig Drugs; 2008 Apr 15; 9(4):379-95. PubMed ID: 18393105
    [Abstract] [Full Text] [Related]

  • 32. Elucidation of Mycobacterium tuberculosis type II dehydroquinase inhibitors using a fragment elaboration strategy.
    Tran AT, West NP, Britton WJ, Payne RJ.
    ChemMedChem; 2012 Jun 15; 7(6):1031-43. PubMed ID: 22461418
    [Abstract] [Full Text] [Related]

  • 33. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
    de Souza MV, Pais KC, Kaiser CR, Peralta MA, de L Ferreira M, Lourenço MC.
    Bioorg Med Chem; 2009 Feb 15; 17(4):1474-80. PubMed ID: 19188070
    [Abstract] [Full Text] [Related]

  • 34. Synthesis, antifungal and antimycobacterial activities of new bis-imidazole derivatives, and prediction of their binding to P450(14DM) by molecular docking and MM/PBSA method.
    Zampieri D, Mamolo MG, Vio L, Banfi E, Scialino G, Fermeglia M, Ferrone M, Pricl S.
    Bioorg Med Chem; 2007 Dec 01; 15(23):7444-58. PubMed ID: 17888669
    [Abstract] [Full Text] [Related]

  • 35. Bis dihydropyrimidine: synthesis and antimycobacterial activity.
    Ali MA, Manogaran E, Govindasamy J, Sellappan V, Pandian S.
    J Enzyme Inhib Med Chem; 2011 Feb 01; 26(1):149-53. PubMed ID: 20583864
    [Abstract] [Full Text] [Related]

  • 36. Multi-component synthesis of dihydropyrimidines by iodine catalyst at ambient temperature and in-vitro antimycobacterial activity.
    Zalavadiya P, Tala S, Akbari J, Joshi H.
    Arch Pharm (Weinheim); 2009 Aug 01; 342(8):469-75. PubMed ID: 19565601
    [Abstract] [Full Text] [Related]

  • 37. Synthesis and bio-evaluation of alkylaminoaryl phenyl cyclopropyl methanones as antitubercular and antimalarial agents.
    Ajay A, Singh V, Singh S, Pandey S, Gunjan S, Dubey D, Sinha SK, Singh BN, Chaturvedi V, Tripathi R, Ramchandran R, Tripathi RP.
    Bioorg Med Chem; 2010 Dec 01; 18(23):8289-301. PubMed ID: 21041091
    [Abstract] [Full Text] [Related]

  • 38. Design, synthesis and docking studies of quinoline-oxazolidinone hybrid molecules and their antitubercular properties.
    Thomas KD, Adhikari AV, Chowdhury IH, Sandeep T, Mahmood R, Bhattacharya B, Sumesh E.
    Eur J Med Chem; 2011 Oct 01; 46(10):4834-45. PubMed ID: 21880400
    [Abstract] [Full Text] [Related]

  • 39. Novel class of hybrid natural products as antidiabetic agents.
    Raj K, Misra N, Pachauri G, Sharma M, Tamrakar AK, Singh AB, Srivastava AK, Phani Kiran K, Narasimha Rao CV, Prubhu SR.
    Nat Prod Res; 2009 Oct 01; 23(1):60-9. PubMed ID: 19140071
    [Abstract] [Full Text] [Related]

  • 40. Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors.
    Onda K, Shiraki R, Ogiyama T, Yokoyama K, Momose K, Katayama N, Orita M, Yamaguchi T, Furutani M, Hamada N, Takeuchi M, Okada M, Ohta M, Tsukamoto S.
    Bioorg Med Chem; 2008 Dec 01; 16(23):10001-12. PubMed ID: 18952447
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.